Effects of continuous renal replacement therapy on intestinal mucosal barrier function during extracorporeal membrane oxygenation in a porcine model

Journal of Cardiothoracic Surgery

Volumn 9, Issue 1, 2014, Pages

  He, Changsheng ^a,b   Yang, Shuofei ^a,c   Yu, Wenkui ^a,c   Chen, Qiyi ^a,c   Shen, Juanhong ^a,c   Hu, Yimin ^c   Shi, Jialiang ^a,c   Wu, Xingjiang ^a,c   Li, Jieshou ^a,c   Li, Ning ^a,c  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c NANJING UNIVERSITY   (China)

Author keywords

Continuous renal replacement treatment (CRRT); Extracorporeal membrane oxygenation (ECMO); Intestinal mucosal barrier function; Systemic inflammatory response syndrome (SIRS)

Indexed keywords

FATTY ACID BINDING PROTEIN;

ANIMAL; ARTICLE; BACTERIAL TRANSLOCATION; DISEASE MODEL; EXTRACORPOREAL OXYGENATION; INTESTINE MUCOSA; METABOLISM; METHODOLOGY; PATHOLOGY; PERMEABILITY; PHYSIOLOGY; RENAL REPLACEMENT THERAPY; SWINE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE;

ANIMALS; BACTERIAL TRANSLOCATION; DISEASE MODELS, ANIMAL; EXTRACORPOREAL MEMBRANE OXYGENATION; FATTY ACID-BINDING PROTEINS; INTESTINAL MUCOSA; MICROSCOPY, ELECTRON, TRANSMISSION; PERMEABILITY; RENAL REPLACEMENT THERAPY; SWINE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 84899988424     PISSN: None     EISSN: 17498090     Source Type: Journal    
DOI: 10.1186/1749-8090-9-72     Document Type: Article

References (42)

1. MacLaren G, Combes A, Bartlett RH. Contemporary extracorporeal membrane oxygenation for adult respiratory failure: life support in the new era. Intensive Care Med 2012, 38(2):210-220. 10.1007/s00134-011-2439-2, 22147116.
2. Fortenberry JD, Paden ML. Extracorporeal therapies in the treatment of sepsis: experience and promise. Semin Pediatr Infect Dis 2006, 17(2):72-79. 10.1053/j.spid.2006.04.005, 16822469.
3. Chalwin RP, Moran JL, Graham PL. The role of extracorporeal membrane oxygenation for treatment of the adult respiratory distress syndrome: review and quantitative analysis. Anaesth Intensive Care 2008, 36(2):152-161.
4. Schmid C, Philipp A, Hilker M, Rupprecht L, Arlt M, Keyser A, Lubnow M, Muller T. Venovenous extracorporeal membrane oxygenation for acute lung failure in adults. J Heart Lung Transplant 2012, 31(1):9-15. 10.1016/j.healun.2011.07.013, 21885295.
5. Nehra D, Goldstein AM, Doody DP, Ryan DP, Chang Y, Masiakos PT. Extracorporeal membrane oxygenation for nonneonatal acute respiratory failure: the Massachusetts General Hospital experience from 1990 to 2008. Arch Surg 2009, 144(5):427-432. discussion 432, 10.1001/archsurg.2009.45, 19451484.
6. Brogan TV, Thiagarajan RR, Rycus PT, Bartlett RH, Bratton SL. Extracorporeal membrane oxygenation in adults with severe respiratory failure: a multi-center database. Intensive Care Med 2009, 35(12):2105-2114. 10.1007/s00134-009-1661-7, 19768656.
7. Peek GJ, Mugford M, Tiruvoipati R, Wilson A, Allen E, Thalanany MM, Hibbert CL, Truesdale A, Clemens F, Cooper N, Firmin RK, Elbourne D, . collaboration Ct Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet 2009, 374(9698):1351-1363. 10.1016/S0140-6736(09)61069-2, 19762075, collaboration Ct.
8. Davies A, Jones D, Bailey M, Beca J, Bellomo R, Blackwell N, Forrest P, Gattas D, Granger E, Herkes R, Jackson A, McGuinness S, Nair P, Pellegrino V, Pettila V, Plunkett B, Pye R, Torzillo P, Webb S, Wilson M, Ziegenfuss M, . Australia, New Zealand Extracorporeal Membrane Oxygenation Influenza I Extracorporeal membrane oxygenation for 2009 influenza A(H1N1) acute respiratory distress syndrome. JAMA 2009, 30(17):1888-1895. Australia, New Zealand Extracorporeal Membrane Oxygenation Influenza I.
9. Kumar A, Zarychanski R, Pinto R, Cook DJ, Marshall J, Lacroix J, Stelfox T, Bagshaw S, Choong K, Lamontagne F, Turgeon AF, Lapinsky S, Ahern SP, Smith O, Siddiqui F, Jouvet P, Khwaja K, McIntyre L, Menon K, Hutchison J, Hornstein D, Joffe A, Lauzier F, Singh J, Karachi T, Wiebe K, Olafson K, Ramsey C, Sharma S, Dodek P, et al. Canadian Critical Care Trials Group HNC. Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA 2009, 302(17):1872-1879. 10.1001/jama.2009.1496, 19822627.
10. Hu Y, Lu S, Song Z, Wang W, Hao P, Li J, Zhang X, Yen HL, Shi B, Li T, Guan W, Xu L, Liu Y, Wang S, Zhang X, Tian D, Zhu Z, He J, Huang K, Chen H, Zheng L, Li X, Ping J, Kang B, Xi X, Zha L, Li Y, Zhang Z, Peiris M, Yuan Z. Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance. Lancet 2013, 381(9885):2273-2279. 10.1016/S0140-6736(13)61125-3, 23726392.
11. Mildner RJ, Taub N, Vyas JR, Killer HM, Firmin RK, Field DJ, Kotecha S. Cytokine imbalance in infants receiving extracorporeal membrane oxygenation for respiratory failure. Biol Neonate 2005, 88(4):321-327. 10.1159/000087630, 16113527.
12. Chen Q, Yu W, Shi J, Shen J, Hu Y, Gao T, Zhang J, Xi F, Gong J, Li J, Li N. The effect of venovenous extra-corporeal membrane oxygenation (ECMO) therapy on immune inflammatory response of cerebral tissues in porcine model. J Cardiothorac Surg 2013, 8(1):186. 10.1186/1749-8090-8-186, 3766192, 23985062.
13. Shen J, Yu W, Shi J, Chen Q, Hu Y, Zhang J, Gao T, Xi F, Gong J, He C, Li N, Li J. Effect of venovenous extracorporeal membrane oxygenation on the heart in a healthy piglet model. J Cardiothorac Surg 2013, 8(1):163. 10.1186/1749-8090-8-163, 3706349, 23805777.
14. Yimin H, Wenkui Y, Jialiang S, Qiyi C, Juanhong S, Zhiliang L, Changsheng H, Ning L, Jieshou L. Effects of continuous renal replacement therapy on renal inflammatory cytokines during extracorporeal membrane oxygenation in a porcine model. J Cardiothorac Surg 2013, 8(1):113. 10.1186/1749-8090-8-113, 3648370, 23628149.
15. Kurundkar AR, Killingsworth CR, McIlwain RB, Timpa JG, Hartman YE, He D, Karnatak RK, Neel ML, Clancy JP, Anantharamaiah GM, Maheshwari A. Extracorporeal membrane oxygenation causes loss of intestinal epithelial barrier in the newborn piglet. Pediatr Res 2010, 68(2):128-133. 10.1203/PDR.0b013e3181e4c9f8, 2914515, 20442689.
16. Adrian K, Mellgren K, Skogby M, Friberg LG, Mellgren G, Wadenvik H. Cytokine release during long-term extracorporeal circulation in an experimental model. Artif Organs 1998, 22(10):859-863. 10.1046/j.1525-1594.1998.06121.x, 9790084.
17. Fortenberry JD, Bhardwaj V, Niemer P, Cornish JD, Wright JA, Bland L. Neutrophil and cytokine activation with neonatal extracorporeal membrane oxygenation. J Pediatr 1996, 128(5 Pt 1):670-678.
18. Leaphart CL, Tepas JJ. The gut is a motor of organ system dysfunction. Surgery 2007, 141(5):563-569. 10.1016/j.surg.2007.01.021, 17462455.
19. Mc IRB, Timpa JG, Kurundkar AR, Holt DW, Kelly DR, Hartman YE, Neel ML, Karnatak RK, Schelonka RL, Anantharamaiah GM, Killingsworth CR, Maheshwari A. Plasma concentrations of inflammatory cytokines rise rapidly during ECMO-related SIRS due to the release of preformed stores in the intestine. Lab Invest 2010, 90(1):128-139. 10.1038/labinvest.2009.119, 2799549, 19901912.
20. Skogby M, Adrian K, Friberg LG, Mellgren G, Mellgren K. Influence of hemofiltration on plasma cytokine levels and platelet activation during extra corporeal membrane oxygenation. Scand Cardiovasc J 2000, 34(3):315-320. 10.1080/713783129, 10935780.
21. Mu TS, Palmer EG, Batts SG, Lentz-Kapua SL, Uyehara-Lock JH, Uyehara CF. Continuous renal replacement therapy to reduce inflammation in a piglet hemorrhage-reperfusion extracorporeal membrane oxygenation model. Pediatr Res 2012, 72(3):249-255. 10.1038/pr.2012.69, 22669297.
22. Matsuda K, Hirasawa H, Oda S, Shiga H, Nakanishi K. Current topics on cytokine removal technologies. Ther Apher 2001, 5(4):306-314. 10.1046/j.1526-0968.2001.00361.x, 11724517.
23. Shen J, Yu W, Chen Q, Shi J, Hu Y, Zhang J, Gao T, Xi F, He C, Gong J, Li N, Li J. Continuous Renal Replacement Therapy (CRRT) Attenuates Myocardial Inflammation and Mitochondrial Injury Induced by Venovenous Extracorporeal Membrane Oxygenation (VV ECMO) in a Healthy Piglet Model. Inflammation 2013, 36(5):1186-1193. 10.1007/s10753-013-9654-7, 23700116.
24. Chiu CJ, McArdle AH, Brown R, Scott HJ, Gurd FN. Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal. Arch Surg 1970, 101(4):478-483. 10.1001/archsurg.1970.01340280030009, 5457245.
25. Ko WJ, Lin CY, Chen RJ, Wang SS, Lin FY, Chen YS. Extracorporeal membrane oxygenation support for adult postcardiotomy cardiogenic shock. Ann Thorac Surg 2002, 73(2):538-545. 10.1016/S0003-4975(01)03330-6, 11845871.
26. Schmid C, Philipp A, Mueller T, Hilker M. Extracorporeal life support - systems, indications, and limitations. Thorac Cardiovasc Surg 2009, 57(8):449-454. 10.1055/s-0029-1186149, 20013616.
27. Hirthler M, Simoni J, Dickson M. Elevated levels of endotoxin, oxygen-derived free radicals, and cytokines during extracorporeal membrane oxygenation. J Pediatr Surg 1992, 27(9):1199-1202. 10.1016/0022-3468(92)90787-8, 1432529.
28. Piena M, Albers MJ, Van Haard PM, Gischler S, Tibboel D. Introduction of enteral feeding in neonates on extracorporeal membrane oxygenation after evaluation of intestinal permeability changes. J Pediatr Surg 1998, 33(1):30-34. 10.1016/S0022-3468(98)90355-4, 9473094.
29. Gatt M, Reddy BS, MacFie J. Review article: bacterial translocation in the critically ill-evidence and methods of prevention. Aliment Pharmacol Ther 2007, 25(7):741-757.
30. Funaoka H, Kanda T, Kajiura S, Ohkaru Y, Fujii H. Development of a high-specificity sandwich ELISA system for the quantification of human intestinal fatty acid-binding protein (I-FABP) concentrations. Immunol Invest 2011, 40(3):223-242. 10.3109/08820139.2010.534216, 21204605.
31. Laws EG, Freeman DE. Effects of heparin, venous strangulation obstruction of the small intestine, and reperfusion of the small intestine on plasma diamine oxidase activity in horses. Am J Vet Res 1994, 55(2):185-191.
32. Tsunooka N, Maeyama K, Hamada Y, Imagawa H, Takano S, Watanabe Y, Kawachi K. Bacterial translocation secondary to small intestinal mucosal ischemia during cardiopulmonary bypass. Measurement by diamine oxidase and peptidoglycan. Eur J Cardiothorac Surg 2004, 25(2):275-280. 10.1016/j.ejcts.2003.11.008, 14747126.
33. Zhang JB, Du XG, Zhang H, Li ML, Xiao G, Wu J, Gan H. Breakdown of the gut barrier in patients with multiple organ dysfunction syndrome is attenuated by continuous blood purification: effects on tight junction structural proteins. Int J Artif Organs 2010, 33(1):5-14.
34. Hennessy VL, Hicks RE, Niewiarowski S, Edmunds LH, Colman RW. Function of human platelets during extracorporeal circulation. Am J Physiol 1977, 232(6):H622-H628.
35. Oda S, Sadahiro T, Hirayama Y, Nakamura M, Watanabe E, Tateishi Y, Hirasawa H. Non-renal indications for continuous renal replacement therapy: current status in Japan. Contrib Nephrol 2010, 166:47-53.
36. De Vriese AS, Vanholder RC, Pascual M, Lameire NH, Colardyn FA. Can inflammatory cytokines be removed efficiently by continuous renal replacement therapies?. Intensive Care Med 1999, 25(9):903-910. 10.1007/s001340050981, 10501744.
37. Banan A, Fields JZ, Zhang Y, Keshavarzian A. iNOS upregulation mediates oxidant-induced disruption of F-actin and barrier of intestinal monolayers. Am J Physiol Gastrointest Liver Physiol 2001, 280(6):G1234-G1246.
38. Costantini TW, Loomis WH, Putnam JG, Drusinsky D, Deree J, Choi S, Wolf P, Baird A, Eliceiri B, Bansal V, Coimbra R. Burn-induced gut barrier injury is attenuated by phosphodiesterase inhibition: effects on tight junction structural proteins. Shock 2009, 31(4):416-422. 10.1097/SHK.0b013e3181863080, 3445035, 18791495.
39. Costantini TW, Deree J, Loomis W, Putnam JG, Choi S, Baird A, Eliceiri BP, Bansal V, Coimbra R. Phosphodiesterase inhibition attenuates alterations to the tight junction proteins occludin and ZO-1 in immunostimulated Caco-2 intestinal monolayers. Life Sci 2009, 84(1-2):18-22.
40. Askenazi DJ, Selewski DT, Paden ML, Cooper DS, Bridges BC, Zappitelli M, Fleming GM. Renal replacement therapy in critically ill patients receiving extracorporeal membrane oxygenation. Clin J Am Soc Nephrol 2012, 7(8):1328-1336. 10.2215/CJN.12731211, 22498496.
41. Smith AH, Hardison DC, Worden CR, Fleming GM, Taylor MB. Acute renal failure during extracorporeal support in the pediatric cardiac patient. ASAIO J 2009, 55(4):412-416. 10.1097/MAT.0b013e31819ca3d0, 19381083.
42. Hirasawa H. Indications for blood purification in critical care. Contrib Nephrol 2010, 166:21-30.